Category

• Pipeline2

Organizations

• Bausch + Lomb66
• Eyes On Eyecare47
• Alcon, Inc.44
• American Optometric Association35
• Harrow29
• Glaukos26
• Regeneron23
• Topcon Healthcare23
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• Retina2
• AMD1
• DME1
• Clinical Trials1
• Gene Therapy1
• Injections1
• Retinitis Pigmentosa1
• Suprachoroidal Space1

• Organizations: Coave Therapeutics✕

Clear all

Pipeline

Coave Therapeutics debuts lead SCS gene therapy for retinal vascular diseases

In-office, suprachoroidal delivery of CoTx-101 offers potential for durable and long-lasting vision gains in treating wet AMD and DME.

Pipeline

Positive 12-month data reported in Coave's ongoing RP phase 1/2 trial

Gene therapy candidate targets treatment for a rare form of retinitis pigmentosa: PDE6B RP.